Table 4 Residual tumor size and CCC between radiological measurements and pathology by immunoistochemistry
Pathologic residual tumor size (cm) | MG residual microcalcifications (cm) | MRI residual enhancement | |||
|---|---|---|---|---|---|
Size (cm) | CCC (95% CI) | Size (cm) | CCC (95% CI) | ||
All patients | 3.7 ± 2.6 | 5.3 ± 2.3 | 0.1962 (− 0.1087–0.4673) | 2.6 ± 2.1 | 0.5660 (0.2997–0.7505) |
ER status | |||||
(+) | 4.2 ± 2.6 | 4.7 ± 2.2 | 0.5629 (0.1622–0.8043) | 2.5 ± 2.1 | 0.4496 (0.0982–0.7013) |
(−) | 2.9 ± 2.4 | 6.4 ± 2.1 | − 0.0162 (− 0.2852–0.2552) | 2.7 ± 2.1 | 0.8584 (0.5692–0.9586) |
PR status | |||||
(+) | 4.4 ± 2.8 | 5.5 ± 1.9 | 0.1881 (− 0.2547–0.5657) | 2.6 ± 2.3 | 0.4588 (0.0635–0.7296) |
(−) | 2.9 ± 2.0 | 5.1 ± 2.7 | 0.1683 (− 0.2173–0.5015) | 2.5 ± 1.9 | 0.7920 (0.4810–0.9260) |
HER2 status | |||||
(+) | 3.1 ± 2.1 | 5.2 ± 2.7 | 0.0323 (− 0.2986–0.3562) | 2.2 ± 1.9 | 0.6606 (0.3303–0.8468) |
(−) | 4.7 ± 2.9 | 5.5 ± 1.6 | 0.5472 (0.1459–0.7939) | 3.1 ± 2.4 | 0.4279 (− 0.0806–0.7597) |